|
|
Volumn 52, Issue 3, 2010, Pages 1170-1171
|
|
Twelve-week posttreatment follow-up predicts a sustained virological response to pegylated interferon and ribavirin therapy
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PEGINTERFERON ALPHA2A;
RIBAVIRIN;
VIRUS RNA;
ALPHA INTERFERON;
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
ANTIVIRUS AGENT;
MACROGOL DERIVATIVE;
PEGINTERFERON ALPHA2B;
RECOMBINANT PROTEIN;
FOLLOW UP;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
LETTER;
PRIORITY JOURNAL;
TREATMENT DURATION;
TREATMENT RESPONSE;
COHORT ANALYSIS;
DRUG COMBINATION;
DRUG EFFECTS;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
PHYSIOLOGY;
PREDICTIVE VALUE;
TIME;
TREATMENT OUTCOME;
VIRUS LOAD;
ANTIVIRAL AGENTS;
COHORT STUDIES;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2A;
INTERFERON ALFA-2B;
POLYETHYLENE GLYCOLS;
PREDICTIVE VALUE OF TESTS;
RIBAVIRIN;
TIME FACTORS;
TREATMENT OUTCOME;
VIRAL LOAD;
INTERFERON-ALPHA;
RECOMBINANT PROTEINS;
|
|
EID: 77956625537
PISSN: 02709139
EISSN: 15273350
Source Type: Journal
DOI: 10.1002/hep.23685 Document Type: Letter |
|
Times cited : (9)
|
|
References (4)
|
